TY - JOUR T1 - SARS-CoV-2 phylodynamics differentiates the effectiveness of non-pharmaceutical interventions JF - medRxiv DO - 10.1101/2020.08.24.20180927 SP - 2020.08.24.20180927 AU - Jean-Philippe Rasigade AU - Anaïs Barray AU - Julie Teresa Shapiro AU - Charlène Coquisart AU - Yoann Vigouroux AU - Antonin Bal AU - Grégory Destras AU - Philippe Vanhems AU - Bruno Lina AU - Laurence Josset AU - Thierry Wirth Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/08/27/2020.08.24.20180927.abstract N2 - Quantifying the effectiveness of large-scale non-pharmaceutical interventions against COVID-19 is critical to adapting responses against future waves of the pandemic. By combining phylogenetic data of 5,198 SARS-CoV-2 genomes with the chronology of non-pharmaceutical interventions in 57 countries, we examine how interventions and combinations thereof alter the divergence rate of viral lineages, which is directly related to the epidemic reproduction number. Home containment and education lockdown had the largest independent impacts and were predicted to reduce the reproduction number by 35% and 26%, respectively. However, we find that in contexts with a reproduction number >2, no individual intervention is sufficient to stop the epidemic and increasingly stringent intervention combinations may be required. Our phylodynamic approach can complement epidemiological models to inform public health strategies against COVID-19.Competing Interest StatementBL is currently active in groups advising the French government for which BL is not receiving payment.Funding StatementJPR received support from the FINOVI Foundation (grant R18037CC).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesBoth data and analysis code are available online at https://github.com/rasigadelab/covid-npi. https://github.com/rasigadelab/covid-npi ER -